Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Stevanovic

Showing results (81-90 of 137) with videos related to

Pageof 14
Sort By:
International Journal of Cancer|March 29, 2002
Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatmentCarmen Scheibenbogen, Yuansheng Sun, Ulrich Keilholz, et al.
The Prostate|March 10, 2009
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancerSusan Feyerabend, Stefan Stevanovic, Cécile Gouttefangeas, et al.
Frontiers in Immunology|April 8, 2020
Immunogenicity and Immune Silence in Human CancerMark Yarmarkovich, Alvin Farrel, Artemio Sison, et al.
Proteomics|May 20, 2011
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cellsBarbara Seliger, Sven P Dressler, Chiara Massa, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)Daniel J Kowalewski, Heiko Schuster, Linus Backert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytesKerstin Schag, Susanne M Schmidt, Martin R Müller, et al.
Molecular & Cellular Proteomics : MCP|November 1, 2006
Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surfaceAndreas O Weinzierl, Claudia Lemmel, Oliver Schoor, et al.
Nature Communications|July 30, 2016
Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactantsDennis Hanzelmann, Hwang-Soo Joo, Mirita Franz-Wachtel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cellsMaha Ayyoub, Charles S Hesdorffer, Genevieve Metthez, et al.
International Journal of Cancer|April 28, 2005
Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2Annette Paschen, Weiqing Jing, Ingo Drexler, et al.
Pageof 14

Showing results (81-90 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|March 29, 2002
Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatmentCarmen Scheibenbogen, Yuansheng Sun, Ulrich Keilholz, et al.
The Prostate|March 10, 2009
Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancerSusan Feyerabend, Stefan Stevanovic, Cécile Gouttefangeas, et al.
Frontiers in Immunology|April 8, 2020
Immunogenicity and Immune Silence in Human CancerMark Yarmarkovich, Alvin Farrel, Artemio Sison, et al.
Proteomics|May 20, 2011
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cellsBarbara Seliger, Sven P Dressler, Chiara Massa, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)Daniel J Kowalewski, Heiko Schuster, Linus Backert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytesKerstin Schag, Susanne M Schmidt, Martin R Müller, et al.
Molecular & Cellular Proteomics : MCP|November 1, 2006
Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surfaceAndreas O Weinzierl, Claudia Lemmel, Oliver Schoor, et al.
Nature Communications|July 30, 2016
Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactantsDennis Hanzelmann, Hwang-Soo Joo, Mirita Franz-Wachtel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+ T cellsMaha Ayyoub, Charles S Hesdorffer, Genevieve Metthez, et al.
International Journal of Cancer|April 28, 2005
Melanoma patients respond to a new HLA-A*01-presented antigenic ligand derived from a multi-epitope region of melanoma antigen TRP-2Annette Paschen, Weiqing Jing, Ingo Drexler, et al.
Pageof 14